David Bailey - Orthopediatrics Corp Executive Vice President
| KIDS Stock | USD 26.47 0.97 3.80% |
President
Mr. David R. Bailey is Executive Vice President of the Company. Since 2009. Mr. Bailey joined our company in 2007 and has served as our Executive Vice President since 2009. Mr. Bailey also served as a member of our board of directors from 2007 to 2013. Prior to joining our company, Mr. Bailey worked as a sales representative and distributor for Smith Nephew plc since 2009.
| Age | 45 |
| Tenure | 15 years |
| Address | 2850 Frontier Drive, Warsaw, IN, United States, 46582 |
| Phone | 574 268 6379 |
| Web | https://www.orthopediatrics.com |
David Bailey Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Bailey against Orthopediatrics Corp stock is an integral part of due diligence when investing in Orthopediatrics Corp. David Bailey insider activity provides valuable insight into whether Orthopediatrics Corp is net buyers or sellers over its current business cycle. Note, Orthopediatrics Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Orthopediatrics Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Bailey over three months ago Acquisition by David Bailey of 90395 shares of Orthopediatrics Corp subject to Rule 16b-3 |
Orthopediatrics Corp Management Efficiency
The company has return on total asset (ROA) of (0.0394) % which means that it has lost $0.0394 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0763) %, meaning that it created substantial loss on money invested by shareholders. Orthopediatrics Corp's management efficiency ratios could be used to measure how well Orthopediatrics Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.08 in 2024. Return On Capital Employed is likely to drop to -0.07 in 2024. At this time, Orthopediatrics Corp's Asset Turnover is comparatively stable compared to the past year.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| James Cunniff | Electromed | 58 | |
| Kevin Kenny | Orthofix Medical | 59 | |
| John Kennedy | CONMED | 66 | |
| Johonna Pelletier | CONMED | 51 | |
| Kimberley Elting | Orthofix Medical | 59 | |
| Joseph Gilliam | Glaukos Corp | 48 | |
| David Vort | iRhythm Technologies | 58 | |
| Stanley Peters | CONMED | 45 | |
| Keyna Skeffington | LivaNova PLC | 61 | |
| Stephanie Bolton | LivaNova PLC | 42 | |
| Peter Shagory | CONMED | 55 | |
| Scott Yerby | Si Bone | 56 | |
| Franco Poletti | LivaNova PLC | N/A | |
| Alex Thurman | Glaukos Corp | 54 | |
| David Murray | CONMED | 76 | |
| Stanley III | CONMED | 49 | |
| Paul Buckman | LivaNova PLC | 68 | |
| Heather Cohen | CONMED | 51 | |
| Todd Garner | CONMED | 55 | |
| Tyler Lipschultz | Orthofix Medical | 57 | |
| Terence Berge | CONMED | 54 | |
Management Performance
| Return On Equity | -0.0763 | ||||
| Return On Asset | -0.0394 |
Orthopediatrics Corp Leadership Team
Elected by the shareholders, the Orthopediatrics Corp's board of directors comprises two types of representatives: Orthopediatrics Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orthopediatrics. The board's role is to monitor Orthopediatrics Corp's management team and ensure that shareholders' interests are well served. Orthopediatrics Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orthopediatrics Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel JD, General Legal | ||
| MBAMSHA CHE, President Technologies | ||
| Daniel Gerritzen, General Counsel and Vice President of Legal and Human Resources | ||
| Joel Batts, Senior Affairs | ||
| David Bailey, Executive Vice President | ||
| Mark Throdahl, President CEO, Director | ||
| Fred Hite, CFO, Director | ||
| Joseph Hauser, President Correction | ||
| Gregory Odle, Executive Vice President | ||
| Mark Karshner, Senior Sales |
Orthopediatrics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Orthopediatrics Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0763 | ||||
| Return On Asset | -0.0394 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 614.11 M | ||||
| Shares Outstanding | 24.22 M | ||||
| Shares Owned By Insiders | 32.52 % | ||||
| Shares Owned By Institutions | 70.80 % | ||||
| Number Of Shares Shorted | 913.9 K | ||||
| Price To Earning | (10.06) X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Orthopediatrics Stock Analysis
When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.